‌

US Patent 10155726 Substituted pyridines and uses thereof

Patent 10155726 was granted and assigned to Peloton Therapeutics on December, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Peloton Therapeutics

Current Assignee

Peloton Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

December 18, 2018

Patent Application Number

15553570

Date Filed

March 4, 2016

Patent Citations Received

US Patent 10807948 Aromatic compounds and uses thereof

US Patent 11753366 Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

US Patent 11267782 Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors

US Patent 12077506 Indane derivatives as hypoxia inducible factor-2(α) inhibitors

0

US Patent 11420936 Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases

US Patent 10335388 Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof

US Patent 10597366 Aryl ethers and uses thereof

US Patent 10786480 Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof

Patent Primary Examiner

Patent abstract

Substituted pyridines that modulate HIF-2a activity, pharmaceutical compositions containing the substituted pyridines, and methods of using these chemical entities for treating proliferative diseases and conditions associated with HIF-2a activity are described herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10155726 Substituted pyridines and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.